FindTrial
Sign In

Assessment of Varnya Lepa Suncreen Lotion in healthy individuals

Development and Clinical Evaluation of Varnya Lepa Sunscreen Lotion

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027895
Enrollment
20
Registered
2020-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L599- Disorder of the skin and subcutaneous tissue related to radiation, unspecified

Interventions

Intervention1: Varnya Lepa Suncreen Lotion: Persons will apply Varnya Lepa Suncreen Lotion on face daily for 1 month with Q.S dose. Control Intervention1: Varnya Lepa Suncreen Lotion: Healthy Persons

Sponsors

Dr Shikha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Healthy Persons should pass skin irritability test. 2)Age group in between 20ââ?¬â??50 years. 3)Willing to give consent for participating in the study. 4)All type of skin color will be included.

Exclusion criteria

Exclusion criteria: 1)History of major medical illness such as Tuberculosis, Cardiac ailments, Bronchial asthma etc. 2)Person who is having severe skin allergy must be excluded. 3)Person who is having severe wound, injury, eczema, leucoderma etc.

Design outcomes

Primary

MeasureTime frame
A novel Varnya lepa sunscreen lotion may be prepared, Physico-chemically analyzed and evaluate clinically for safety and efficacyTimepoint: 18 months—

Secondary

MeasureTime frame
To compare the effect of Varnya Lepa Suncreen Lotion with standard Lactocalamine Suncreen lotionTimepoint: 18 months—

Countries

India

Contacts

Public ContactDr P G Jadar

KAHERs Shri BMK Ayurveda Mahavidalaya shahapur Belagavi

drjadar@yahoo.co.in9448301308

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026